Newsroom
Client news
The latest news from Optimum clients
Optimum’s EU Life Science Investor Survey 2025
Download for direct insights from leading European investors
Weekly wrap-up
Read Optimum’s round-up for the low-down on client and industry news
Hot topic: JPM shines bright amid the January gloom
/in InsightsWeekly round-up: Optimum’s clients fight off the January blues as JP Morgan conference sets positive tone for ‘25
/in InsightsHot topic: The blues are costing business millions – so how can firms keep their staff happy?
/in InsightsWeekly round-up: With an innovative cancer tie-up and a €90m Series A financing, Optimum’s clients kick off 2025 in style
/in InsightsHot topic: Will you live longer than your parents… or not?
/in InsightsThe must attend healthcare conferences in Winter/Spring 2025
/in InsightsOptimum’s clients shine in major mergers, approvals and awards in ‘24
/in InsightsOptimum showcases cutting-edge life sciences R&D in ‘24
/in InsightsOptimum’s clients raise nearly US$2bn in ’24, with more to come in ’25!
/in InsightsWeekly round-up: Ottimo Pharma Raises over $140 Million in Series A Financing
/in InsightsWeekly round-up: Optimum’s European Life Sciences Investor Survey strikes optimistic note for 2025
/in InsightsIndustry leading survey of Venture Capital (VC) life sciences investors of funds managing c.$300bn
/in Insights, Optimum newsOptimum’s European Life Sciences Investor Survey 2025
/in InsightsWeekly round-up: Renée Aguiar-Lucander, Calliditas Therapeutics’ former CEO, scoops Executive of the Year Scrip Award
/in InsightsOptimum’s hot topic: Can we ‘bottle’ the remarkable biology of people who, against all odds, beat killer diseases?
/in Insights